Novo Nordisk's experimental obesity drug CagriSema shows blood pressure benefits US$ 27.47 Min. order: 1 piece ★★★★★ 4.2 (11 reviews) Sold : Login>>
Novo Nordisk defends disappointing next-gen obesity drug: 'It will be an important product' – NBC Connecticut US$ 20.10 Min. order: 1 piece ★★★★★ 4.6 (18 reviews) Sold : Login>>
Novo Nordisk: Can CagriSema Show 25% Weight Loss In REDEFINE-1 Trial? US$ 25.41 Min. order: 1 piece ★★★★★ 4.3 (240 reviews) Sold : Login>>
Novo Nordisk Files NDA for CagriSema, Novel GLP-1-amylin Combination for Chronic Weight Management US$ 29.56 Min. order: 1 piece ★★★★★ 4.3 (121 reviews) Sold : Login>>